Trial intelligence / Profile preview

Osteofortil vs Forteo in Postmenopausal Osteoporosis

NCT01945788Phase 4Unknown

Sponsor
Biosidus
Start
Jun 2013
Primary completion
Oct 2014
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of Osteofortil in postmenopausal osteoporosis, sponsored by Biosidus. Status: unknown.

02

Drugs

Osteofortil
03

Conditions

postmenopausal osteoporosis

Beyond the preview

Go deeper on NCT01945788.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01945788.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call